Resistance and cross-resistance to first generation integrase inhibitors: insights from a Phase II study of elvitegravir (GS-9137)D. J. McColl,S. Fransen,S. Gupta,N. Parkin,N. Margot,S. Chuck,A. K. Cheng,M. D. MillerANTIVIRAL THERAPY（2007）引用 6|浏览5AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
